Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Autoimmun ; 81: 56-67, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28385374

ABSTRACT

Medullary thymic epithelial cells (mTECs) contribute to self-tolerance by expressing and presenting peripheral tissue antigens for negative selection of autoreactive T cells and differentiation of natural regulatory T cells. The molecular control of mTEC development remains incompletely understood. We here demonstrate by TEC-specific gene manipulation in mice that the NF-κB transcription factor subunit RelB, which is activated by the alternative NF-κB pathway, regulates development of mature mTECs in a dose-dependent manner. Mice with conditional deletion of Relb lacked mature mTECs and developed spontaneous autoimmunity. In addition, the NF-κB subunits RelA and c-Rel, which are both activated by classical NF-κB signaling, were jointly required for mTEC differentiation by directly regulating the transcription of Relb. Our data reveal a crosstalk mechanism between classical and alternative NF-κB pathways that tightly controls the development of mature mTECs to ensure self-tolerance.


Subject(s)
Central Tolerance/immunology , Epithelial Cells/metabolism , NF-kappa B/metabolism , Signal Transduction , Thymus Gland/immunology , Thymus Gland/metabolism , Animals , Autoimmunity/genetics , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Line , Dendritic Cells/immunology , Dendritic Cells/metabolism , Epithelial Cells/cytology , Gene Expression , Liver/immunology , Liver/metabolism , Liver/pathology , Lung/immunology , Lung/metabolism , Lung/pathology , Mice , Mice, Knockout , Mice, Transgenic , NF-kappa B/genetics , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , T-Lymphocytes/immunology , T-Lymphocytes/metabolism , TNF Receptor-Associated Factor 6/metabolism
2.
J Allergy Clin Immunol ; 139(5): 1525-1535, 2017 May.
Article in English | MEDLINE | ID: mdl-27670239

ABSTRACT

BACKGROUND: Chronic immune diseases, such as asthma, are highly prevalent. Currently available pharmaceuticals improve symptoms but cannot cure the disease. This prompted demands for alternatives to pharmaceuticals, such as probiotics, for the prevention of allergic disease. However, clinical trials have produced inconsistent results. This is at least partly explained by the highly complex crosstalk among probiotic bacteria, the host's microbiota, and immune cells. The identification of a bioactive substance from probiotic bacteria could circumvent this difficulty. OBJECTIVE: We sought to identify and characterize a bioactive probiotic metabolite for potential prevention of allergic airway disease. METHODS: Probiotic supernatants were screened for their ability to concordantly decrease the constitutive CCL17 secretion of a human Hodgkin lymphoma cell line and prevent upregulation of costimulatory molecules of LPS-stimulated human dendritic cells. RESULTS: Supernatants from 13 of 37 tested probiotic strains showed immunoactivity. Bioassay-guided chromatographic fractionation of 2 supernatants according to polarity, followed by total ion chromatography and mass spectrometry, yielded C11H12N2O2 as the molecular formula of a bioactive substance. Proton nuclear magnetic resonance and enantiomeric separation identified D-tryptophan. In contrast, L-tryptophan and 11 other D-amino acids were inactive. Feeding D-tryptophan to mice before experimental asthma induction increased numbers of lung and gut regulatory T cells, decreased lung TH2 responses, and ameliorated allergic airway inflammation and hyperresponsiveness. Allergic airway inflammation reduced gut microbial diversity, which was increased by D-tryptophan. CONCLUSIONS: D-tryptophan is a newly identified product from probiotic bacteria. Our findings support the concept that defined bacterial products can be exploited in novel preventative strategies for chronic immune diseases.


Subject(s)
Asthma/immunology , Cytokines/immunology , Gastrointestinal Microbiome/immunology , Probiotics , Tryptophan/biosynthesis , Animals , Bacteria/metabolism , Cell Line, Tumor , Cells, Cultured , Dendritic Cells , Female , Humans , Lipopolysaccharides , Mice, Inbred BALB C
3.
Science ; 349(6251): 989-93, 2015 Aug 28.
Article in English | MEDLINE | ID: mdl-26160380

ABSTRACT

Changes to the symbiotic microbiota early in life, or the absence of it, can lead to exacerbated type 2 immunity and allergic inflammations. Although it is unclear how the microbiota regulates type 2 immunity, it is a strong inducer of proinflammatory T helper 17 (T(H)17) cells and regulatory T cells (T(regs)) in the intestine. Here, we report that microbiota-induced T(regs) express the nuclear hormone receptor RORγt and differentiate along a pathway that also leads to T(H)17 cells. In the absence of RORγt(+) T(regs), T(H)2-driven defense against helminths is more efficient, whereas T(H)2-associated pathology is exacerbated. Thus, the microbiota regulates type 2 responses through the induction of type 3 RORγt(+) T(regs) and T(H)17 cells and acts as a key factor in balancing immune responses at mucosal surfaces.


Subject(s)
Immunity, Mucosal , Intestinal Mucosa/immunology , Intestinal Mucosa/microbiology , Intestines/microbiology , Microbiota/immunology , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , T-Lymphocytes, Regulatory/immunology , Animals , Colitis, Ulcerative/immunology , Colon/immunology , Colon/microbiology , Germ-Free Life , Homeostasis , Intestine, Small/immunology , Intestine, Small/microbiology , Intestines/immunology , Mice , Models, Immunological , Nematospiroides dubius , Specific Pathogen-Free Organisms , Strongylida Infections/immunology , T-Lymphocyte Subsets/immunology , T-Lymphocytes, Regulatory/metabolism , Th17 Cells/immunology , Th2 Cells/immunology , Vitamin A/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...